93 related articles for article (PubMed ID: 21883695)
21. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
22. Alpha-bisabolol: unexpected plant-derived weapon in the struggle against tumour survival?
Darra E; Lenaz G; Cavalieri E; Fato R; Mariotto S; Bergamini C; Carcereri de Prati A; Perbellini L; Leoni S; Suzuki H
Ital J Biochem; 2007 Dec; 56(4):323-8. PubMed ID: 19192636
[TBL] [Abstract][Full Text] [Related]
23. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation.
Awale S; Lu J; Kalauni SK; Kurashima Y; Tezuka Y; Kadota S; Esumi H
Cancer Res; 2006 Feb; 66(3):1751-7. PubMed ID: 16452235
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
25. Involvement of mitochondrial permeability transition pore opening in alpha-bisabolol induced apoptosis.
Cavalieri E; Bergamini C; Mariotto S; Leoni S; Perbellini L; Darra E; Suzuki H; Fato R; Lenaz G
FEBS J; 2009 Aug; 276(15):3990-4000. PubMed ID: 19570051
[TBL] [Abstract][Full Text] [Related]
26. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
28. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
29. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
30. N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation.
Guo G; Yao G; Zhan G; Hu Y; Yue M; Cheng L; Liu Y; Ye Q; Qing G; Zhang Y; Liu H
Toxicol Appl Pharmacol; 2014 Nov; 280(3):475-83. PubMed ID: 25151971
[TBL] [Abstract][Full Text] [Related]
31. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer.
Kano MT; Kokuryo T; Baba T; Yamazaki K; Yamaguchi J; Sunagawa M; Ogura A; Watanabe N; Onoe S; Miyata K; Mizuno T; Uehara K; Igami T; Yokoyama Y; Ebata T; Nagino M
Anticancer Res; 2023 Mar; 43(3):1009-1016. PubMed ID: 36854520
[TBL] [Abstract][Full Text] [Related]
32. A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model.
Iwaki K; Shibata K; Ohta M; Endo Y; Uchida H; Tominaga M; Okunaga R; Kai S; Kitano S
Int J Cancer; 2008 Feb; 122(3):658-63. PubMed ID: 17935125
[TBL] [Abstract][Full Text] [Related]
33. The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?
Chirumbolo S; Bjørklund G
Int J Clin Oncol; 2017 Apr; 22(2):222-228. PubMed ID: 27942879
[TBL] [Abstract][Full Text] [Related]
34. Alpha-bisabolol Promotes Glioma Cell Death by Modulating the Adenosinergic System.
Mendes FB; Bergamin LS; Dos Santos Stuepp C; Braganhol E; Terroso T; Pohlmann AR; Guterres SS; Battastini AM
Anticancer Res; 2017 Apr; 37(4):1819-1823. PubMed ID: 28373446
[TBL] [Abstract][Full Text] [Related]
35. PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo.
Michl J; Scharf B; Schmidt A; Huynh C; Hannan R; von Gizycki H; Friedman FK; Brandt-Rauf P; Fine RL; Pincus MR
Int J Cancer; 2006 Oct; 119(7):1577-85. PubMed ID: 16688716
[TBL] [Abstract][Full Text] [Related]
36. The antineoplastic agent α-bisabolol promotes cell death by inducing pores in mitochondria and lysosomes.
Rigo A; Vinante F
Apoptosis; 2016 Aug; 21(8):917-27. PubMed ID: 27278818
[TBL] [Abstract][Full Text] [Related]
37. α-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3.
Fang D; Wang H; Li M; Wei W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31127027
[TBL] [Abstract][Full Text] [Related]
38. Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha.
Suzuki T; Sato F; Kondo J; Liu Y; Kusumi T; Fujimoto K; Kato Y; Sato T; Kijima H
Biomed Res; 2008 Apr; 29(2):99-103. PubMed ID: 18480551
[TBL] [Abstract][Full Text] [Related]
39. Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol.
Eddin LB; Jha NK; Goyal SN; Agrawal YO; Subramanya SB; Bastaki SMA; Ojha S
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405982
[TBL] [Abstract][Full Text] [Related]
40. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment.
Baron B; Kitagawa T; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):49-55. PubMed ID: 25770187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
